- About
- Projects
- Column 1
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Food & Nutrition
- Column 2
- Column 1
- News and Events
- Expanded Access eRequest
Medscape: FDA Pushes for Buprenorphine Labeling Changes to Facilitate Higher Doses
The FDA noted that a Reagan-Udall Foundation public meeting in the spring of 2023 — with FDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) — and a December 2023 meeting with FDA, SAMHSA, and the National Institute on Drug Abuse helped shed more light on the ongoing barriers to the use of higher dosages. The FDA labeling was determined to be one of the biggest impediments.
Food Safety Magazine: Food Safety in Transition: Looking Toward FSMA 204 Compliance
Additionally, the Reagan-Udall Foundation held a series of roundtables with industry members to share insights from those involved in implementation, identify and prioritize key issues, and explore implementation strategies.
Advancing FDA Mechanisms to Address Complex Cross-Sectoral Health Threats
At FDA’s request, the Foundation is identifying opportunities for the agency to address challenges at the intersection of human and animal health sectors, including those in the ongoing response to the current H5N1 outbreak.
Food Navigator USA: Does FDA's proposed front-of-pack nutrition labeling miss the mark?
Her sentiments echo concerns raised by the Rudd Center for Food Policy & Health at a public meeting hosted by The Reagan-Udall Foundation for FDA in November 2023.